cancer
Online CPM Advertising
|
Advertising blog
Saturday, May 16, 2009
A Phase I/II Study of Docetaxel and Gemcitabine Combination for Chemotherapy-resistant Ovarian Cancer.
No comments:
Loading...
.
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment